Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials

Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials

For optimal personalization of treatment for metastatic spinal cord compression (MSCC), the patient’s survival prognosis should be considered. Estimation of survival can be facilitated by prognostic factors. This study investigated the prognostic value of pre-treatment preclinical markers, namely he...

Full description

Bibliographic Details
Main Authors: Dirk Rades, Jon Cacicedo, Darejan Lomidze, Ahmed Al-Salool, Barbara Segedin, Blaz Groselj, Steven E. Schild
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
metastatic spinal cord compression
radiotherapy
prospective trials
survival
prognostic factors
preclinical markers
Online Access:https://www.mdpi.com/2072-6694/14/10/2547

Internet

https://www.mdpi.com/2072-6694/14/10/2547

Similar Items